Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic anti‐amyloid β antibodies cause neuronal disturbances
Utpal Kumar Adhikari, Rizwan Hasan Khan, Meena Mikhael, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 6, pp. 2479-2496
Open Access | Times Cited: 15

Showing 15 citing articles:

Cranial bone maneuver ameliorates Alzheimer's disease pathology via enhancing meningeal lymphatic drainage function
Xuan Lu, Shanshan Bai, Feng Lu, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 2
Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System
Kenneth Maiese
Biomolecules (2023) Vol. 13, Iss. 5, pp. 816-816
Open Access | Times Cited: 21
GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders
Ferdinando Nicoletti, Luisa Di Menna, Luisa Iacovelli, et al.
Neuropharmacology (2023) Vol. 235, pp. 109569-109569
Closed Access | Times Cited: 20
The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk
Kenneth Maiese
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Longitudinal markers of cerebral amyloid angiopathy and related inflammation in rTg-DI rats
Joseph M. Schrader, Feng Xu, Kevin Agostinucci, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Cognitive Impairment in Multiple Sclerosis
Kenneth Maiese
Bioengineering (2023) Vol. 10, Iss. 7, pp. 871-871
Open Access | Times Cited: 11
Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK
Kenneth Maiese
Cells (2023) Vol. 12, Iss. 22, pp. 2595-2595
Open Access | Times Cited: 11
Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazone
Francesca Catto, Daniel S. Kirschenbaum, Athena Economides, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0309489-e0309489
Open Access
Sex- and dose-dependent catalase increase and its clinical impact in a benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease
Hsien‐Yuan Lane, Shi‐Heng Wang, Chieh‐Hsin Lin
Pharmacology Biochemistry and Behavior (2024) Vol. 245, pp. 173885-173885
Closed Access | Times Cited: 2
The Implications of Telomere Length: Advanced Aging, Cell Senescence, MRI Phenotypes, Stem Cells and Alzheimer’s Disease
Kenneth Maiese
Current Neurovascular Research (2023) Vol. 20, Iss. 2, pp. 171-174
Closed Access | Times Cited: 6
Anti-amyloid treatments in Alzheimer’s disease: elegance, evidence and ethics
Timothy Daly, Andi Olluri, Markku Kurkinen
Advances in Clinical and Experimental Medicine (2024) Vol. 33, Iss. 12, pp. 1303-1309
Open Access | Times Cited: 1
Toxicologic Neuropathology of Novel Biotherapeutics
Dinesh S. Bangari, Lisa G. Lanigan, Sarah D. Cramer, et al.
Toxicologic Pathology (2023) Vol. 51, Iss. 7-8, pp. 414-431
Closed Access | Times Cited: 3
Dimethyl Fumarate as Potential Treatment for Alzheimer’s Disease: Rationale and Clinical Trial Design
Robert Sharkus, Richa Thakkar, Dennis L. Kolson, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1387-1387
Open Access | Times Cited: 1
Ethical Issues Around Treatment-Induced Amyloid-Related Imaging Abnormalities in Alzheimer's Disease
Timothy Daly
Journal of Radiology Nursing (2024) Vol. 43, Iss. 3, pp. 214-217
Closed Access
Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazone
Francesca Catto, Ehsan Dadgar‐Kiani, Daniel S. Kirschenbaum, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top